News & Updates
Filter by Specialty:
Investigative drug for ulcerative colitis passes muster in early trial
The orally administered, small molecule, gut-targeted stabiliser of hypoxia-inducible factor-1α (HIF-1α) GB004 appears to improve disease activity in patients with ulcerative colitis, with the drug being well-tolerated, according to the results of a phase Ib trial.
Investigative drug for ulcerative colitis passes muster in early trial
25 Jan 2022
Can digital health revolutionize IBD management?
Digital health technologies (DHTs) can help lower healthcare utilization and costs but appear to have not enough juice to reduce the risk of relapse, improve quality of life (QoL), and increase treatment adherence in patients with inflammatory bowel disease (IBD), according to a study.
Can digital health revolutionize IBD management?
13 Jan 2022
GI symptoms in COVID-19 more prevalent than previously reported
There appears to be a higher prevalence of gastrointestinal (GI) symptoms in hospitalized patients with COVID-19 than previously reported, reveals a recent study.
GI symptoms in COVID-19 more prevalent than previously reported
13 Jan 2022
The 5:2 diet: Is it worth the hype?
The benefits of the 5:2 diet – which involves limited caloric intake (500–600 kcal) for 2 nonconsecutive days per week only – mirrored those achieved with a multicomponent weight management advice, according to a UK study on adults with obesity. However, the benefits eventually waned, even when intensified with group support.
The 5:2 diet: Is it worth the hype?
12 Jan 2022
Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns
The coronavirus disease 2019 (COVID-19) pandemic has led to a sharp decline in treatment for older patients with newly diagnosed cancers of the digestive system, a recent study has found.